Humility in defeat Wednesday, January 5, 2022
Cowboy commit Kawecki built through losing seasons Daniel Allen Staff Reporter
Chris Becker
Lebanon Trail, Kawecki remained fairly under the radar for the majority of his high school career. Following a promising junior season, Jackson assisted Kawecki in gathering tape. Once his junior season film was released, he started gaining more attention, eventually leading to a multitude of power 5 offers. “After the coaches got a hold of that junior film, (Kawecki) really started to blow up,” Jackson said. “He became one of, if not the hottest recruit in north Texas.” Kawecki took an official visit to OSU on June 22 and was immediately bought into the culture and atmosphere in Stillwater. “I could tell after that official visit back in June that Oklahoma State was where he wanted to be,” Jackson said. “He was talking about it for I can’t even tell you how much and I knew it was only a matter of time (before he committed).” Since his commitment, Jackson says the coaching staff at Oklahoma State has checked on him consistently. He also says that it seems like the coaches genuinely care about him, as opposed to others who want to come off as caring to keep the recruit bought in and remain committed. “There’s no doubt in my mind that (Kawecki) will be able to adjust to basically anything that the coaches will throw at him,” Jackson said. “The biggest thing for Austin is his need to realize that college football is a much faster, bigger, and stronger level of football than Texas high school football. “Once that clicks in his mind, there’s no question, no sense of doubt from me that Austin will be a star at Oklahoma State.”
Sadd Jackson has seen a significant amount of his players go on to play football at the college level. One of them being class of 2022 three-star offensive lineman Austin Kawecki, who is currently committed to Oklahoma State. However, Jackson says in his six years at Lebanon Trail, he has yet to see someone as humble as Kawecki. “Austin knows he is good,” Jackson said. “I know he is good too. But his whole demeanor basically prevents him from coming off as cocky. His whole personality is humble in and of itself.” During Kawecki’s four years at Lebanon Trail, it has been difficult. His high school football career has involved just one winning season, and no playoff appearances. In the midst of this, Kawecki has shown nothing but passion and the desire to make not only himself better, but his teammates and the people around him. “Losing is tough for sure, that pretty much goes without saying.” Jackson said. “With that being said, it really hasn’t seemed to bother (Kawecki) too much from my knowledge. He is the kind of kid who shows up every day, is the first one to practice, the first one to the weight room, you pretty much get the picture. “So, stuff even as hard as losing a football game, just doesn’t phase him. He’ll show up the next day ready to work.” Despite playing on a losing team, Kawecki’s talent outweighed all else as he currently holds offers from the likes of Auburn, Arkansas, SMU and other notable names. Even after a productive first two seasons at sports.ed@ocolly.com
Pfizer’s COVID-19 booster shot for younger teens wins FDA clearance Timothy Annett and a booster dose at least six months after a second Riley Griffin shot. Bloomberg News Peter Marks, the di-
rector of the FDA’s Center for Biologics Evaluation WASHINGTON — and Research, said on a U.S. regulators cleared call with reporters that Pfizer Inc.’s COVID-19 the agency decided to booster shot for younger shorten the interval beadolescents, widening tween Pfizer shots based access to additional doses on data submitted by the as parents seek to procompany. Marks said the tect their kids from the FDA was open to considomicron wave and school ering similar data from officials try to keep class- Moderna if the company rooms open. submits it. The Food and Drug In addition to clearAdministration said ing Pfizer boosters for on Monday that it had younger teens, the FDA granted an emergency-use also said that immuneauthorization for people compromised children ages 12 to 15 to receive a age 5 to 11 could receive third dose of the messen- a third primary-series ger RNA vaccine, which Pfizer shot at least 28 days Pfizer developed with following their initial BioNTech SE. two-dose immunization. The agency also Shares of Pfizer, reduced the recommended which soared last year as interval between the the company benefited second and third doses of from high global demand the Pfizer vaccine for all for its shot, were down ages to five months. The 3.8% to $56.83 at 1:21 FDA still recommends p.m. in New York. recipients of the Moderna Inc. vaccine, which is also based on mRNA, receive See Booster on 2
Tribune News Service